PubRank
Search
About
K F Browne
Author PubWeight™ 32.28
‹?›
Top papers
Rank
Title
Journal
Year
PubWeight™
‹?›
1
A comparison of immediate angioplasty with thrombolytic therapy for acute myocardial infarction. The Primary Angioplasty in Myocardial Infarction Study Group.
N Engl J Med
1993
6.52
2
Adenosine as an adjunct to thrombolytic therapy for acute myocardial infarction: results of a multicenter, randomized, placebo-controlled trial: the Acute Myocardial Infarction STudy of ADenosine (AMISTAD) trial.
J Am Coll Cardiol
1999
2.23
3
Influence of the autonomic nervous system on the Q-T interval in man.
Am J Cardiol
1982
1.45
4
Outcome of different reperfusion strategies in patients with former contraindications to thrombolytic therapy: a comparison of primary angioplasty and tissue plasminogen activator. Primary Angioplasty in Myocardial Infarction (PAMI) Investigators.
Cathet Cardiovasc Diagn
1996
1.43
5
Predictors of in-hospital and 6-month outcome after acute myocardial infarction in the reperfusion era: the Primary Angioplasty in Myocardial Infarction (PAMI) trail.
J Am Coll Cardiol
1995
1.40
6
Worse six-month outcome for patients with multiple stents in a single coronary artery.
J Invasive Cardiol
1999
1.39
7
Pseudobacteremia traced to cross-contamination by an automated blood culture analyzer.
Infect Control
1984
1.33
8
Prolongation of the Q-T interval in man during sleep.
Am J Cardiol
1983
1.25
9
Analysis of the relative costs and effectiveness of primary angioplasty versus tissue-type plasminogen activator: the Primary Angioplasty in Myocardial Infarction (PAMI) trial. The PAMI Trial Investigators.
J Am Coll Cardiol
1997
1.11
10
Long-term outcome after primary angioplasty: report from the primary angioplasty in myocardial infarction (PAMI-I) trial.
J Am Coll Cardiol
1999
1.05
11
Clinical transvenous cardioversion of recurrent life-threatening ventricular tachyarrhythmias: low energy synchronized cardioversion of ventricular tachycardia and termination of ventricular fibrillation in patients using a catheter electrode.
Am Heart J
1982
1.01
12
Comparison of in-hospital outcome in men versus women treated by either thrombolytic therapy or primary coronary angioplasty for acute myocardial infarction.
Am J Cardiol
1995
0.94
13
Beneficial effects of RheothRx injection in patients receiving thrombolytic therapy for acute myocardial infarction. Results of a randomized, double-blind, placebo-controlled trial.
Circulation
1996
0.93
14
Coronary artery perforation repair using microcoil embolization.
Cathet Cardiovasc Diagn
1998
0.88
15
Adverse reactions of low osmolality contrast media during cardiac angiography: a prospective randomized multicenter study.
J Am Coll Cardiol
1992
0.84
16
Modulation of the Q-T interval by the autonomic nervous system.
Pacing Clin Electrophysiol
1983
0.84
17
Contrast nephropathy after coronary angioplasty in chronic renal insufficiency.
Am Heart J
1996
0.84
18
Multicenter reperfusion trial of intravenous anisoylated plasminogen streptokinase activator complex (APSAC) in acute myocardial infarction: controlled comparison with intracoronary streptokinase.
J Am Coll Cardiol
1988
0.81
19
Functional bundle branch block: discordant response of right and left bundle branches to changes in heart rate.
Am J Cardiol
1984
0.81
20
Intracardiac recording by catheter electrode of accessory pathway depolarization.
J Am Coll Cardiol
1983
0.80
21
Influence of acute myocardial infarction location on in-hospital and late outcome after primary percutaneous transluminal coronary angioplasty versus tissue plasminogen activator therapy.
Am J Cardiol
1996
0.78
22
Electrophysiologic effects and clinical efficacy of oral propafenone therapy in patients with ventricular tachycardia.
J Am Coll Cardiol
1985
0.78
23
Multicenter patency trial of intravenous anistreplase compared with streptokinase in acute myocardial infarction. The TEAM-2 Study Investigators.
Circulation
1991
0.78
24
Implications of recurrent ischemia after reperfusion therapy in acute myocardial infarction: a comparison of thrombolytic therapy and primary angioplasty.
J Am Coll Cardiol
1995
0.77
25
Additional observations on transvenous cardioversion of recurrent ventricular tachycardia.
Am Heart J
1982
0.76
26
Potentially lethal arrhythmias and driving.
Ann Intern Med
1992
0.75
27
Anistreplase versus alteplase in acute myocardial infarction: comparative effects on left ventricular function, morbidity and 1-day coronary artery patency. The TEAM-3 Investigators.
J Am Coll Cardiol
1992
0.75
28
Acute reocclusion during percutaneous transluminal coronary angioplasty: immediate and long-term outcome.
Cathet Cardiovasc Diagn
1989
0.75
29
Sitting up post angioplasty: a new sheath technology.
Cathet Cardiovasc Diagn
1992
0.75
30
Clinical efficacy and electrophysiologic effects of cibenzoline therapy in patients with ventricular arrhythmias.
J Am Coll Cardiol
1984
0.75
31
Prolongation of the QT interval induced by probucol: demonstration of a method for determining QT interval change induced by a drug.
Am Heart J
1984
0.75
32
Five-hour balloon inflation to resolve recurrent reocclusion during coronary angioplasty.
Cathet Cardiovasc Diagn
1991
0.75
33
Intra-aortic balloon counterpulsation in an experimental model of myocardial infarction.
Chest
1983
0.75
34
Interventional cardiology techniques for coronary artery disease.
J Card Surg
1991
0.75
35
Peripartum bacteremia with CDC group HB-5 (Pasteurella bettyae).
Clin Infect Dis
1996
0.75